154 related articles for article (PubMed ID: 34392955)
1. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract][Full Text] [Related]
2. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).
Solheim O; Gershenson DM; Tropé CG; Rokkones E; Sun CC; Weedon-Fekjaer H; Fosså SD
Eur J Cancer; 2014 Jul; 50(11):1942-50. PubMed ID: 24857045
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors.
Wang J; Zhuo X; Yang J; Cao D; Shen K; Huang H; Wu M; Pan L; Xiang Y; Guo L
Arch Gynecol Obstet; 2020 Apr; 301(4):1021-1026. PubMed ID: 32198624
[TBL] [Abstract][Full Text] [Related]
5. Incidence of malignant ovarian germ cell tumors (MOGCTs) in Saudi Arabia.
Abu-Zaid A; Nazer A; Alomar O; Azzam A; Al-Eid HS; Elhassan TA; Al-Badawi IA
Hematol Oncol Stem Cell Ther; 2014 Mar; 7(1):41-3. PubMed ID: 24412326
[TBL] [Abstract][Full Text] [Related]
6. Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012.
Lee SH; Jung KW; Ha J; Oh CM; Kim H; Park HJ; Yoo H; Won YJ
Cancer Res Treat; 2017 Apr; 49(2):494-501. PubMed ID: 27554477
[TBL] [Abstract][Full Text] [Related]
7. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
Wang J; Chen R; Li J; Lu X
Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
[TBL] [Abstract][Full Text] [Related]
8. Trends in the surgical management of malignant ovarian germcell tumors.
Nasioudis D; Mastroyannis SA; Latif NA; Ko EM
Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006.
Poynter JN; Amatruda JF; Ross JA
Cancer; 2010 Oct; 116(20):4882-91. PubMed ID: 20597129
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
[TBL] [Abstract][Full Text] [Related]
12. [Malignant ovarian germ cell tumors--clinical characteristics and analysis of outcomes].
Miedzińska-Maciejewska M; Bobkiewicz P; Gawrychowski K
Ginekol Pol; 2011 May; 82(5):338-43. PubMed ID: 21851031
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Features, Prognostic Factors, Survival Trends, and Treatment of Malignant Ovarian Germ Cell Tumors: A SEER Database Analysis.
Guo H; Chen H; Wang W; Chen L
Oncol Res Treat; 2021; 44(4):145-153. PubMed ID: 33706324
[TBL] [Abstract][Full Text] [Related]
14. A Nationwide, Population-Based Epidemiologic Study of Childhood Brain Tumors in Korea, 2005-2014: A Comparison with United States Data.
Kang JM; Ha J; Hong EK; Ju HY; Park BK; Shin SH; Won YJ; Jung KW; Park HJ
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):409-416. PubMed ID: 30348678
[TBL] [Abstract][Full Text] [Related]
15. Incidence and survival rates for female malignant germ cell tumors.
Smith HO; Berwick M; Verschraegen CF; Wiggins C; Lansing L; Muller CY; Qualls CR
Obstet Gynecol; 2006 May; 107(5):1075-85. PubMed ID: 16648414
[TBL] [Abstract][Full Text] [Related]
16. [Malignant ovarian germ cell tumors. Current status of diagnosis and treatment].
Torres-Lobatón A
Ginecol Obstet Mex; 2014 Mar; 82(3):177-87. PubMed ID: 24779273
[TBL] [Abstract][Full Text] [Related]
17. MALIGNANT OVARIAN GERM CELL TUMORS AT A TERTIARY CARE SETTING IN PAKISTAN.
Hannan A; Malik MA; Fasih S; Badar F; Siddiqui N
J Ayub Med Coll Abbottabad; 2015; 27(3):624-7. PubMed ID: 26721024
[TBL] [Abstract][Full Text] [Related]
18. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
Xu W; Li Y
Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population.
Bownes LV; Stafman LL; Maizlin II; Dellinger M; Gow KW; Goldin AB; Goldfarb M; Langer M; Raval MV; Doski JJ; Nuchtern JG; Vasudevan SA; Beierle EA
J Surg Res; 2018 Feb; 222():180-186.e3. PubMed ID: 28988685
[TBL] [Abstract][Full Text] [Related]
20. Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis.
Lin KY; Bryant S; Miller DS; Kehoe SM; Richardson DL; Lea JS
Gynecol Oncol; 2014 Jul; 134(1):84-9. PubMed ID: 24836278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
